A patient with neurological symptoms and abnormal leukotriene metabolism: A new defect in leukotriene biosynthesis

Annals of Neurology

Volumn 58, Issue 6, 2005, Pages 968-970

  Mayatepek, Ertan ^a   Badiou, Stéphanie ^b   Bellet, Hélène ^b   Lehmann, Wolf D ^c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HÔPITAL SAINT ELOI   (France)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDASE; LEUKOTRIENE; LEUKOTRIENE D4; LEUKOTRIENE E4;

ADOLESCENT; ARTICLE; BIOSYNTHESIS; CASE REPORT; CLINICAL FEATURE; ENZYME DEFICIENCY; HEARING IMPAIRMENT; HUMAN; ICOSANOID METABOLISM; MALE; MENTAL DEFICIENCY; MOTOR DYSFUNCTION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; URINE LEVEL;

ADOLESCENT; DEAFNESS; HUMANS; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; MALE; MENTAL RETARDATION; NEUROMUSCULAR DISEASES; SRS-A;

EID: 28544442344     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20687     Document Type: Article

References (15)

1. Mayatepek E, Hoffmann GF. Leukotrienes: biosynthesis, metabolism and pathophysiological significance. Pediatr Res 1995; 37:1-9.
2. Simmet T, Luck W, Delank WK, Peskar BA. Formation of cysteinyl- leukotrienes by human brain tissue. Brain Res 1988; 456:344-349.
3. Palmer MR, Mathews R, Murphy RC, Hoffer BJ. Leukotriene C elicits a prolonged excitation of cetebellar Purkinje neurons. Neurosci Lett 1980;18:173-180.
4. 4-synthesis deficiency: a new inborn error of metabolism linked to a fatal developmental syndrome. Lancet 1998;352:1514-1517.
5. Mayatepek E, Okun J, Meissner T, et al. Synthesis and metabolism of leukotrienes in γ-glutamyl transpeptidase deficiency. J Lipid Res 2004;45:900-904.
6. Bellet H, Rejou F, Vallat C, et al. Cystinylglycinuria: a new neurometabolic disorder? J Inher Metab Dis 1999;22:231-234.
7. Mayatepek E, Hoffmann GF, Carlsson B, et al. Impaired synthesis of lipoxygenase products in glutathione synthetase deficiency. Pediatr Res 1994;35:307-310.
8. Antoine C, Lellouche JP, Maclouf J, Pradelles P. Development of enzyme immuno-assays for leukotrienes using acetylcholinesterase. Biochim Biophys Acta 1991;1075:162-168.
9. 4 synthesis deficiency: a member of a probably underdiagnosed new group of neurometabolic diseases. Eur J Pediatr 2000;159:811-818.
10. Armstrong MD. The occurrence of cystinylglycine in blood plasma. Biochim Biophys Acta 1979;584:542-544.
11. Badiou S, Bellet H, Lehmann S, et al. Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment. Clin Chem Lab Med 2005;43:332-334.
12. Kozak EM, Tate SS. Glutathione-degrading enzymes of microvillus membranes. J Biol Chem 1982;257:6322-6327.
13. Chen XS, Sheller JR, Johnson EN, Funk CD. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 1994;372:179-182.
14. Harding CO, Williams P, Wagner E, et al. Mice with genetic γ-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility. J Biol Chem 1997;272:12560-12567.
15. 4 and cysinyl-bis-glycine metabolism in membrane-bound dipeptidase-deficient mice. Proc Natl Acad Sci USA 1998;95:4859-4863.